Insider trading

Period: 120 months Stock: NVCR Plan: Not stated × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

450 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

450 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

450 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

450 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
450 decisions over 120 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
450 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

450 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
7 Mar 2023
Leonard Frank X President, CNS Cancers US
Sold, plan not stated 2×
$625.21K 8,318 at 75.16
13.3%
3 Mar 2023
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated 3×
$1.95M 25,635 at 76.16
10.9%
3 Mar 2023
Shah Pritesh Chief Growth Officer
Sold, plan not stated 3×
$1.63M 21,421 at 76.16
14.6%
3 Mar 2023
Leonard Frank X President, CNS Cancers US
Sold, plan not stated 3×
$562.82K 7,350 at 76.57
10.5%
3 Mar 2023
Cordova Ashley Chief Financial Officer
Sold, plan not stated 2×
$419.26K 5,505 at 76.16
5.2%
3 Mar 2023
Burke William Patrick Chief Human Resources Officer
Sold, plan not stated
$45.16K 593 at 76.16
0.9%
2 Mar 2023
Leonard Frank X President, CNS Cancers US
Sold, plan not stated 3×
$373.11K 4,951 at 75.36
7.8%
2 Mar 2023
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated
$91.31K 1,213 at 75.28
0.7%
2 Mar 2023
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$79.42K 1,055 at 75.28
1.1%
2 Mar 2023
Shah Pritesh Chief Growth Officer
Sold, plan not stated
$70.54K 937 at 75.28
0.9%
2 Mar 2023
Burke William Patrick Chief Human Resources Officer
Sold, plan not stated
$21.15K 281 at 75.28
0.4%
1 Mar 2023
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$167.84K 2,198 at 76.36
2.2%
1 Mar 2023
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated
$165.25K 2,164 at 76.36
1.2%
1 Mar 2023
Shah Pritesh Chief Growth Officer
Sold, plan not stated
$146.84K 1,923 at 76.36
1.9%
1 Mar 2023
Leonard Frank X President, CNS Cancers US
Sold, plan not stated
$128.59K 1,684 at 76.36
2.6%
1 Mar 2023
Burke William Patrick Chief Human Resources Officer
Sold, plan not stated
$57.65K 755 at 76.36
1.1%
5 Jan 2023
Danziger Asaf Chief Executive Officer
Sold, plan not stated 10×
$23.11M 212,500 at 108.74
94.0%
Sold half or more
5 Jan 2023
Leonard Frank X President, CNS Cancers US
Sold, plan not stated 9×
$4.43M 39,507 at 112.25
46.1%
5 Jan 2023
Weinberg Uri Chief Science Officer
Sold, plan not stated 4×
$945.76K 8,143 at 116.14
15.8%
5 Jan 2023
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$41.80K 387 at 108.00
0.5%
13 Oct 2022
Leonard Frank X President, CNS Cancers US
Sold, plan not stated
$513.37K 6,754 at 76.01
13.4%
6 Oct 2022
Leonard Frank X President, CNS Cancers US
Sold, plan not stated
$569.83K 6,754 at 84.37
11.8%
29 Sep 2022
Leonard Frank X President, CNS Cancers US
Sold, plan not stated
$522.42K 6,754 at 77.35
10.6%
22 Sep 2022
Leonard Frank X President, CNS Cancers US
Sold, plan not stated
$520.06K 6,754 at 77.00
9.6%
15 Sep 2022
Leonard Frank X Chief Development Officer
Sold, plan not stated 2×
$1.09M 12,271 at 88.52
14.8%
9 Sep 2022
Leonard Frank X Chief Development Officer
Sold, plan not stated
$163.94K 1,863 at 88.00
2.2%
6 Sep 2022
Leonard Frank X Chief Development Officer
Sold, plan not stated
$108.74K 1,384 at 78.57
1.6%
2 Sep 2022
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$69.95K 885 at 79.04
1.2%
2 Sep 2022
Burke William Patrick Chief Human Resources Officer
Sold, plan not stated
$56.75K 718 at 79.04
1.3%
2 Sep 2022
Leonard Frank X Chief Development Officer
Sold, plan not stated
$46.16K 584 at 79.04
0.7%
2 Sep 2022
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated
$23.39K 296 at 79.04
0.2%
2 Sep 2022
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$21.26K 269 at 79.04
0.3%
1 Sep 2022
Leonard Frank X Chief Development Officer
Sold, plan not stated 12×
$1.10M 14,212 at 77.43
13.9%
3 Aug 2022
Benaim Ely Chief Medical Officer
Sold, plan not stated 2×
$439.33K 5,959 at 73.73
17.2%
2 Aug 2022
DOYLE WILLIAM F Executive Chairman
Sold, plan not stated
$58.30K 837 at 69.66
0.2%
2 Aug 2022
Benaim Ely Chief Medical Officer
Sold, plan not stated
$30.44K 437 at 69.66
1.2%
2 Aug 2022
Leonard Frank X Chief Development Officer
Sold, plan not stated
$28.84K 414 at 69.66
0.4%
10 Jun 2022
HILLEMAN JERYL L Director
Sold, plan not stated
$28.33K 407 at 69.61
13.8%
11 May 2022
Benaim Ely Chief Medical Officer
Sold, plan not stated
$130.77K 2,135 at 61.25
5.8%
10 May 2022
Benaim Ely Chief Medical Officer
Sold, plan not stated
$134.88K 2,070 at 65.16
5.3%
9 Mar 2022
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$261.20K 3,669 at 71.19
4.2%
8 Mar 2022
GROENHUYSEN WILHELMUS CM Chief Operating Officer
Sold, plan not stated
$204.90K 2,923 at 70.10
1.7%
8 Mar 2022
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$173.92K 2,481 at 70.10
2.9%
8 Mar 2022
DOYLE WILLIAM F Executive Chairman
Sold, plan not stated
$167.19K 2,385 at 70.10
0.4%
8 Mar 2022
Longsworth Todd Christopher General Counsel
Sold, plan not stated
$163.96K 2,339 at 70.10
3.6%
8 Mar 2022
Burke William Patrick Chief Human Resources Officer
Sold, plan not stated
$72.69K 1,037 at 70.10
1.8%
8 Mar 2022
Cordova Ashley Chief Financial Officer
Sold, plan not stated
$53.21K 759 at 70.10
1.2%
8 Mar 2022
Leonard Frank X Chief Development Officer
Sold, plan not stated
$52.15K 744 at 70.10
0.7%
7 Mar 2022
Shah Pritesh Chief Commercial Officer
Sold, plan not stated
$368.20K 5,294 at 69.55
5.9%
4 Mar 2022
Shah Pritesh Chief Commercial Officer
Sold, plan not stated 2×
$327.79K 4,546 at 72.11
4.8%
Showing 1–50 of 450. Page 1 of 9 Older →